Michael Logan

2.4k total citations
62 papers, 1.7k citations indexed

About

Michael Logan is a scholar working on Molecular Biology, Immunology and Cell Biology. According to data from OpenAlex, Michael Logan has authored 62 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Immunology and 12 papers in Cell Biology. Recurrent topics in Michael Logan's work include Cellular transport and secretion (12 papers), Hepatitis C virus research (11 papers) and Anesthesia and Sedative Agents (7 papers). Michael Logan is often cited by papers focused on Cellular transport and secretion (12 papers), Hepatitis C virus research (11 papers) and Anesthesia and Sedative Agents (7 papers). Michael Logan collaborates with scholars based in Canada, United States and United Kingdom. Michael Logan's co-authors include Redwan Moqbel, Solomon O. Odemuyiwa, Paige Lacy, Craig A. Mandato, J.A.W. Wildsmith, J. H. McClure, Gary Eitzen, Michael Houghton, Juan Liao and Elizabeth J. Taparowsky and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Cell Biology.

In The Last Decade

Michael Logan

60 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Logan Canada 25 486 458 314 250 218 62 1.7k
P J Dawson United States 20 453 0.9× 107 0.2× 283 0.9× 114 0.5× 145 0.7× 59 1.5k
Flavio Lejbkowicz Israel 21 1.0k 2.1× 206 0.4× 125 0.4× 210 0.8× 39 0.2× 55 2.0k
Helen M. McGuire Australia 21 443 0.9× 1.2k 2.6× 211 0.7× 101 0.4× 24 0.1× 86 2.2k
Hiroki Mori Japan 26 693 1.4× 132 0.3× 931 3.0× 101 0.4× 333 1.5× 189 2.4k
Sheraz Yaqub Norway 24 395 0.8× 1.0k 2.2× 674 2.1× 46 0.2× 388 1.8× 84 2.5k
Yuushi Okumura Japan 26 789 1.6× 365 0.8× 179 0.6× 165 0.7× 34 0.2× 59 2.0k
Klaus Degitz Germany 31 586 1.2× 690 1.5× 209 0.7× 347 1.4× 99 0.5× 81 3.0k
Thomas Ahrens United States 18 999 2.1× 926 2.0× 179 0.6× 862 3.4× 28 0.1× 31 2.5k
Stefan Meyer United Kingdom 22 863 1.8× 525 1.1× 132 0.4× 146 0.6× 11 0.1× 77 2.5k
Daniel L. Worthley Australia 24 935 1.9× 419 0.9× 401 1.3× 74 0.3× 51 0.2× 64 2.3k

Countries citing papers authored by Michael Logan

Since Specialization
Citations

This map shows the geographic impact of Michael Logan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Logan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Logan more than expected).

Fields of papers citing papers by Michael Logan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Logan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Logan. The network helps show where Michael Logan may publish in the future.

Co-authorship network of co-authors of Michael Logan

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Logan. A scholar is included among the top collaborators of Michael Logan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Logan. Michael Logan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koshman, Yevgeniya E., Rebecca Kohnken, Michael Logan, Scott W. Mittelstadt, & C. Michael Foley. (2024). Preclinical cardiovascular safety assessment of pharmacology-toxicology relationship for a set of novel kinase inhibitors. Toxicological Sciences. 198(2). 316–327.
2.
Hossain, Faisal, John Lok Man Law, Michael Logan, et al.. (2023). Utilization of a Glucometer Test Strip and Enzymatic Reactions to Quantify Anti-SARS-CoV-2 Spike RBD IgG Antibody and SARS-CoV-2 Virus in Saliva and Serum. Analytical Chemistry. 95(19). 7620–7629. 8 indexed citations
3.
Kanai, Tapan, Zongyi Hu, Renbin Yang, et al.. (2022). Three-Dimensional Reconstruction of the Hepatitis C Virus Envelope Glycoprotein E1E2 Heterodimer by Electron Microscopic Analysis. Journal of Virology. 97(1). e0178822–e0178822. 1 indexed citations
4.
Law, John Lok Man, Michael Logan, Michael Joyce, et al.. (2021). SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1. Vaccine. 39(40). 5769–5779. 24 indexed citations
6.
Landi, Abdolamir, John Law, Darren Hockman, et al.. (2017). Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes. Vaccine. 35(50). 6949–6956. 32 indexed citations
7.
Douglas, Donna N., Jamie T. Lewis, Rakesh Bhat, et al.. (2015). Oxidative Stress Attenuates Lipid Synthesis and Increases Mitochondrial Fatty Acid Oxidation in Hepatoma Cells Infected with Hepatitis C Virus. Journal of Biological Chemistry. 291(4). 1974–1990. 39 indexed citations
8.
Eitzen, Gary & Michael Logan. (2011). Analysis of Rho GTPase Activation in Saccharomyces cerevisiae. Methods in molecular biology. 827. 369–380. 4 indexed citations
9.
Steffen, Imke, D. Lorne Tyrrell, Leilani Montalvo, et al.. (2011). No Evidence for XMRV Nucleic Acids, Infectious Virus or Anti-XMRV Antibodies in Canadian Patients with Chronic Fatigue Syndrome. PLoS ONE. 6(11). e27870–e27870. 16 indexed citations
10.
Wang, Chuanwu, Seung Goo Kang, Juan Liao, et al.. (2010). Batf coordinates multiple aspects of B and T cell function required for normal antibody responses. The Journal of Experimental Medicine. 207(5). 933–942. 187 indexed citations
11.
Logan, Michael, et al.. (2009). Cdc42p Is Activated during Vacuole Membrane Fusion in a Sterol-dependent Subreaction of Priming. Journal of Biological Chemistry. 285(7). 4298–4306. 17 indexed citations
12.
Logan, Michael, Thao T. T. Nguyen, Paul M. Harrison, et al.. (2008). Genetic interaction network of the Saccharomyces cerevisiae type 1 phosphatase Glc7. BMC Genomics. 9(1). 336–336. 14 indexed citations
13.
Mitchell, Troy, et al.. (2008). Primary granule exocytosis in human neutrophils is regulated by Rac-dependent actin remodeling. American Journal of Physiology-Cell Physiology. 295(5). C1354–C1365. 84 indexed citations
14.
Logan, Michael, Paige Lacy, Solomon O. Odemuyiwa, et al.. (2006). A critical role for vesicle‐associated membrane protein‐7 in exocytosis from human eosinophils and neutrophils. Allergy. 61(6). 777–784. 73 indexed citations
15.
Logan, Michael & Craig A. Mandato. (2006). Regulation of the actin cytoskeleton by PIP2 in cytokinesis. Biology of the Cell. 98(6). 377–388. 108 indexed citations
16.
Logan, Michael, et al.. (2006). “Carry‐on” dermal baggage: a nodule from a dog. Veterinary Clinical Pathology. 35(3). 329–331. 2 indexed citations
17.
Lacy, Paige, Michael Logan, Ben Bablitz, & Redwan Moqbel. (2001). Fusion protein vesicle-associated membrane protein 2 is implicated in IFN-γ–induced piecemeal degranulation in human eosinophils from atopic individuals. Journal of Allergy and Clinical Immunology. 107(4). 671–678. 52 indexed citations
18.
Logan, Michael, et al.. (1999). Effect of sevoflurane concentration on inhalation induction of anaesthesia in the elderly. British Journal of Anaesthesia. 82(1). 20–24. 30 indexed citations
19.
Logan, Michael. (1994). Breathing systems: effect of fresh gas flow rate on enflurane consumption. British Journal of Anaesthesia. 73(6). 775–778. 10 indexed citations
20.
Logan, Michael & Gordon B. Drummond. (1991). CRANIO-CAUDAL MOVEMENT OF THE STERNUM ON INDUCTION OF ANAESTHESIA. British Journal of Anaesthesia. 66(4). 433–436. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026